nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—PNP—Daunorubicin—Epirubicin—testicular cancer	0.0128	0.519	CbGdCrCtD
Didanosine—PNP—Daunorubicin—Doxorubicin—testicular cancer	0.0118	0.481	CbGdCrCtD
Didanosine—Gastrointestinal pain—Vinblastine—testicular cancer	0.00227	0.00233	CcSEcCtD
Didanosine—Anaemia—Ifosfamide—testicular cancer	0.00227	0.00233	CcSEcCtD
Didanosine—Discomfort—Dactinomycin—testicular cancer	0.00225	0.00231	CcSEcCtD
Didanosine—Anorexia—Bleomycin—testicular cancer	0.00224	0.00229	CcSEcCtD
Didanosine—Hypersensitivity—Chlorambucil—testicular cancer	0.00223	0.00229	CcSEcCtD
Didanosine—Diabetes mellitus—Methotrexate—testicular cancer	0.00222	0.00227	CcSEcCtD
Didanosine—Hypoaesthesia—Etoposide—testicular cancer	0.00222	0.00227	CcSEcCtD
Didanosine—Malaise—Ifosfamide—testicular cancer	0.00221	0.00227	CcSEcCtD
Didanosine—Leukopenia—Ifosfamide—testicular cancer	0.0022	0.00225	CcSEcCtD
Didanosine—Abdominal pain—Vinblastine—testicular cancer	0.00219	0.00225	CcSEcCtD
Didanosine—Asthenia—Chlorambucil—testicular cancer	0.00217	0.00223	CcSEcCtD
Didanosine—Infection—Dactinomycin—testicular cancer	0.00217	0.00223	CcSEcCtD
Didanosine—Neuropathy—Doxorubicin—testicular cancer	0.00216	0.00221	CcSEcCtD
Didanosine—Alopecia—Cisplatin—testicular cancer	0.00215	0.0022	CcSEcCtD
Didanosine—Hepatic failure—Methotrexate—testicular cancer	0.00215	0.0022	CcSEcCtD
Didanosine—Pruritus—Chlorambucil—testicular cancer	0.00214	0.0022	CcSEcCtD
Didanosine—Thrombocytopenia—Dactinomycin—testicular cancer	0.00214	0.0022	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00214	0.00219	CcSEcCtD
Didanosine—Dry eye—Doxorubicin—testicular cancer	0.00213	0.00218	CcSEcCtD
Didanosine—Paraesthesia—Bleomycin—testicular cancer	0.00211	0.00216	CcSEcCtD
Didanosine—Myalgia—Ifosfamide—testicular cancer	0.00209	0.00214	CcSEcCtD
Didanosine—Arthralgia—Ifosfamide—testicular cancer	0.00209	0.00214	CcSEcCtD
Didanosine—Renal failure acute—Methotrexate—testicular cancer	0.00209	0.00214	CcSEcCtD
Didanosine—Flatulence—Cisplatin—testicular cancer	0.00209	0.00214	CcSEcCtD
Didanosine—Anorexia—Dactinomycin—testicular cancer	0.00208	0.00214	CcSEcCtD
Didanosine—Diabetes mellitus—Epirubicin—testicular cancer	0.00208	0.00213	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Epirubicin—testicular cancer	0.00208	0.00213	CcSEcCtD
Didanosine—Diarrhoea—Chlorambucil—testicular cancer	0.00207	0.00213	CcSEcCtD
Didanosine—Hepatic function abnormal—Epirubicin—testicular cancer	0.00207	0.00212	CcSEcCtD
Didanosine—Discomfort—Ifosfamide—testicular cancer	0.00207	0.00212	CcSEcCtD
Didanosine—Hypersensitivity—Vinblastine—testicular cancer	0.00205	0.0021	CcSEcCtD
Didanosine—Decreased appetite—Bleomycin—testicular cancer	0.00204	0.00209	CcSEcCtD
Didanosine—Hepatic failure—Epirubicin—testicular cancer	0.00201	0.00206	CcSEcCtD
Didanosine—Pain—Bleomycin—testicular cancer	0.00201	0.00206	CcSEcCtD
Didanosine—Anaphylactic shock—Ifosfamide—testicular cancer	0.002	0.00205	CcSEcCtD
Didanosine—Chills—Etoposide—testicular cancer	0.002	0.00205	CcSEcCtD
Didanosine—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00199	0.00204	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00199	0.00204	CcSEcCtD
Didanosine—Asthenia—Vinblastine—testicular cancer	0.00199	0.00204	CcSEcCtD
Didanosine—Infection—Ifosfamide—testicular cancer	0.00199	0.00204	CcSEcCtD
Didanosine—Alopecia—Etoposide—testicular cancer	0.00197	0.00202	CcSEcCtD
Didanosine—Thrombocytopenia—Ifosfamide—testicular cancer	0.00196	0.00201	CcSEcCtD
Didanosine—Anaemia—Cisplatin—testicular cancer	0.00196	0.00201	CcSEcCtD
Didanosine—Renal failure acute—Epirubicin—testicular cancer	0.00196	0.002	CcSEcCtD
Didanosine—Vomiting—Chlorambucil—testicular cancer	0.00193	0.00197	CcSEcCtD
Didanosine—Diabetes mellitus—Doxorubicin—testicular cancer	0.00192	0.00197	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Doxorubicin—testicular cancer	0.00192	0.00197	CcSEcCtD
Didanosine—Hepatic function abnormal—Doxorubicin—testicular cancer	0.00191	0.00196	CcSEcCtD
Didanosine—Anorexia—Ifosfamide—testicular cancer	0.00191	0.00196	CcSEcCtD
Didanosine—Malaise—Cisplatin—testicular cancer	0.00191	0.00196	CcSEcCtD
Didanosine—Decreased appetite—Dactinomycin—testicular cancer	0.0019	0.00195	CcSEcCtD
Didanosine—Diarrhoea—Vinblastine—testicular cancer	0.0019	0.00195	CcSEcCtD
Didanosine—Renal impairment—Epirubicin—testicular cancer	0.0019	0.00194	CcSEcCtD
Didanosine—Leukopenia—Cisplatin—testicular cancer	0.00189	0.00194	CcSEcCtD
Didanosine—Pain—Dactinomycin—testicular cancer	0.00187	0.00192	CcSEcCtD
Didanosine—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00187	0.00191	CcSEcCtD
Didanosine—Hepatic failure—Doxorubicin—testicular cancer	0.00186	0.00191	CcSEcCtD
Didanosine—Body temperature increased—Bleomycin—testicular cancer	0.00185	0.0019	CcSEcCtD
Didanosine—Hypoglycaemia—Epirubicin—testicular cancer	0.00185	0.0019	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00183	0.00187	CcSEcCtD
Didanosine—Renal failure acute—Doxorubicin—testicular cancer	0.00181	0.00185	CcSEcCtD
Didanosine—Myalgia—Cisplatin—testicular cancer	0.0018	0.00185	CcSEcCtD
Didanosine—Nausea—Chlorambucil—testicular cancer	0.0018	0.00184	CcSEcCtD
Didanosine—Paraesthesia—Ifosfamide—testicular cancer	0.0018	0.00184	CcSEcCtD
Didanosine—Anaemia—Etoposide—testicular cancer	0.00179	0.00184	CcSEcCtD
Didanosine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00179	0.00183	CcSEcCtD
Didanosine—Discomfort—Cisplatin—testicular cancer	0.00178	0.00183	CcSEcCtD
Didanosine—Vomiting—Vinblastine—testicular cancer	0.00177	0.00181	CcSEcCtD
Didanosine—Renal impairment—Doxorubicin—testicular cancer	0.00175	0.0018	CcSEcCtD
Didanosine—Malaise—Etoposide—testicular cancer	0.00175	0.00179	CcSEcCtD
Didanosine—Decreased appetite—Ifosfamide—testicular cancer	0.00174	0.00179	CcSEcCtD
Didanosine—Headache—Vinblastine—testicular cancer	0.00174	0.00178	CcSEcCtD
Didanosine—Leukopenia—Etoposide—testicular cancer	0.00174	0.00178	CcSEcCtD
Didanosine—Abdominal pain—Dactinomycin—testicular cancer	0.00173	0.00177	CcSEcCtD
Didanosine—Body temperature increased—Dactinomycin—testicular cancer	0.00173	0.00177	CcSEcCtD
Didanosine—Anaphylactic shock—Cisplatin—testicular cancer	0.00173	0.00177	CcSEcCtD
Didanosine—Hypersensitivity—Bleomycin—testicular cancer	0.00173	0.00177	CcSEcCtD
Didanosine—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00173	0.00177	CcSEcCtD
Didanosine—Infection—Cisplatin—testicular cancer	0.00172	0.00176	CcSEcCtD
Didanosine—Pain—Ifosfamide—testicular cancer	0.00171	0.00176	CcSEcCtD
Didanosine—Hypoglycaemia—Doxorubicin—testicular cancer	0.00171	0.00175	CcSEcCtD
Didanosine—Thrombocytopenia—Cisplatin—testicular cancer	0.00169	0.00173	CcSEcCtD
Didanosine—Asthenia—Bleomycin—testicular cancer	0.00168	0.00172	CcSEcCtD
Didanosine—Pruritus—Bleomycin—testicular cancer	0.00166	0.0017	CcSEcCtD
Didanosine—Nausea—Vinblastine—testicular cancer	0.00165	0.00169	CcSEcCtD
Didanosine—Abdominal pain upper—Epirubicin—testicular cancer	0.00165	0.00169	CcSEcCtD
Didanosine—Anorexia—Cisplatin—testicular cancer	0.00165	0.00169	CcSEcCtD
Didanosine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00164	0.00168	CcSEcCtD
Didanosine—Pancreatitis—Methotrexate—testicular cancer	0.00163	0.00168	CcSEcCtD
Didanosine—Discomfort—Etoposide—testicular cancer	0.00163	0.00167	CcSEcCtD
Didanosine—Hypersensitivity—Dactinomycin—testicular cancer	0.00161	0.00165	CcSEcCtD
Didanosine—Abdominal pain—Ifosfamide—testicular cancer	0.00158	0.00162	CcSEcCtD
Didanosine—Body temperature increased—Ifosfamide—testicular cancer	0.00158	0.00162	CcSEcCtD
Didanosine—Anaphylactic shock—Etoposide—testicular cancer	0.00158	0.00162	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00157	0.00161	CcSEcCtD
Didanosine—Infection—Etoposide—testicular cancer	0.00157	0.00161	CcSEcCtD
Didanosine—Asthenia—Dactinomycin—testicular cancer	0.00157	0.00161	CcSEcCtD
Didanosine—Paraesthesia—Cisplatin—testicular cancer	0.00155	0.00159	CcSEcCtD
Didanosine—Thrombocytopenia—Etoposide—testicular cancer	0.00155	0.00159	CcSEcCtD
Didanosine—Pancreatitis—Epirubicin—testicular cancer	0.00153	0.00157	CcSEcCtD
Didanosine—Abdominal pain upper—Doxorubicin—testicular cancer	0.00153	0.00156	CcSEcCtD
Didanosine—Anorexia—Etoposide—testicular cancer	0.00151	0.00155	CcSEcCtD
Didanosine—Decreased appetite—Cisplatin—testicular cancer	0.0015	0.00154	CcSEcCtD
Didanosine—Diarrhoea—Dactinomycin—testicular cancer	0.0015	0.00153	CcSEcCtD
Didanosine—Vomiting—Bleomycin—testicular cancer	0.00149	0.00153	CcSEcCtD
Didanosine—Rash—Bleomycin—testicular cancer	0.00148	0.00152	CcSEcCtD
Didanosine—Pain—Cisplatin—testicular cancer	0.00148	0.00151	CcSEcCtD
Didanosine—Dermatitis—Bleomycin—testicular cancer	0.00148	0.00151	CcSEcCtD
Didanosine—Hypersensitivity—Ifosfamide—testicular cancer	0.00148	0.00151	CcSEcCtD
Didanosine—Asthenia—Ifosfamide—testicular cancer	0.00144	0.00147	CcSEcCtD
Didanosine—Paraesthesia—Etoposide—testicular cancer	0.00142	0.00146	CcSEcCtD
Didanosine—Pruritus—Ifosfamide—testicular cancer	0.00142	0.00145	CcSEcCtD
Didanosine—Pancreatitis—Doxorubicin—testicular cancer	0.00142	0.00145	CcSEcCtD
Didanosine—Hyperglycaemia—Epirubicin—testicular cancer	0.00141	0.00144	CcSEcCtD
Didanosine—Hepatobiliary disease—Methotrexate—testicular cancer	0.00141	0.00144	CcSEcCtD
Didanosine—Nausea—Bleomycin—testicular cancer	0.00139	0.00143	CcSEcCtD
Didanosine—Vomiting—Dactinomycin—testicular cancer	0.00139	0.00143	CcSEcCtD
Didanosine—Agranulocytosis—Methotrexate—testicular cancer	0.00139	0.00142	CcSEcCtD
Didanosine—Rash—Dactinomycin—testicular cancer	0.00138	0.00141	CcSEcCtD
Didanosine—Decreased appetite—Etoposide—testicular cancer	0.00138	0.00141	CcSEcCtD
Didanosine—Diarrhoea—Ifosfamide—testicular cancer	0.00137	0.00141	CcSEcCtD
Didanosine—Body temperature increased—Cisplatin—testicular cancer	0.00137	0.0014	CcSEcCtD
Didanosine—Neuropathy peripheral—Epirubicin—testicular cancer	0.00136	0.0014	CcSEcCtD
Didanosine—Pain—Etoposide—testicular cancer	0.00135	0.00139	CcSEcCtD
Didanosine—Hepatitis—Methotrexate—testicular cancer	0.00133	0.00137	CcSEcCtD
Didanosine—Hepatobiliary disease—Epirubicin—testicular cancer	0.00132	0.00135	CcSEcCtD
Didanosine—Hyperglycaemia—Doxorubicin—testicular cancer	0.0013	0.00133	CcSEcCtD
Didanosine—Nausea—Dactinomycin—testicular cancer	0.0013	0.00133	CcSEcCtD
Didanosine—Agranulocytosis—Epirubicin—testicular cancer	0.0013	0.00133	CcSEcCtD
Didanosine—Gastrointestinal pain—Etoposide—testicular cancer	0.00129	0.00133	CcSEcCtD
Didanosine—Vomiting—Ifosfamide—testicular cancer	0.00127	0.00131	CcSEcCtD
Didanosine—Hypersensitivity—Cisplatin—testicular cancer	0.00127	0.0013	CcSEcCtD
Didanosine—Rash—Ifosfamide—testicular cancer	0.00126	0.0013	CcSEcCtD
Didanosine—Dermatitis—Ifosfamide—testicular cancer	0.00126	0.00129	CcSEcCtD
Didanosine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00126	0.00129	CcSEcCtD
Didanosine—Body temperature increased—Etoposide—testicular cancer	0.00125	0.00128	CcSEcCtD
Didanosine—Abdominal pain—Etoposide—testicular cancer	0.00125	0.00128	CcSEcCtD
Didanosine—Hepatitis—Epirubicin—testicular cancer	0.00125	0.00128	CcSEcCtD
Didanosine—Hypoaesthesia—Epirubicin—testicular cancer	0.00124	0.00127	CcSEcCtD
Didanosine—Asthenia—Cisplatin—testicular cancer	0.00124	0.00127	CcSEcCtD
Didanosine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00122	0.00125	CcSEcCtD
Didanosine—Agranulocytosis—Doxorubicin—testicular cancer	0.0012	0.00123	CcSEcCtD
Didanosine—Chills—Methotrexate—testicular cancer	0.0012	0.00123	CcSEcCtD
Didanosine—Nausea—Ifosfamide—testicular cancer	0.00119	0.00122	CcSEcCtD
Didanosine—Diarrhoea—Cisplatin—testicular cancer	0.00118	0.00121	CcSEcCtD
Didanosine—Alopecia—Methotrexate—testicular cancer	0.00118	0.00121	CcSEcCtD
Didanosine—Hypersensitivity—Etoposide—testicular cancer	0.00117	0.0012	CcSEcCtD
Didanosine—Hepatitis—Doxorubicin—testicular cancer	0.00116	0.00118	CcSEcCtD
Didanosine—Hypoaesthesia—Doxorubicin—testicular cancer	0.00115	0.00118	CcSEcCtD
Didanosine—Asthenia—Etoposide—testicular cancer	0.00114	0.00116	CcSEcCtD
Didanosine—Chills—Epirubicin—testicular cancer	0.00112	0.00115	CcSEcCtD
Didanosine—Pruritus—Etoposide—testicular cancer	0.00112	0.00115	CcSEcCtD
Didanosine—Alopecia—Epirubicin—testicular cancer	0.0011	0.00113	CcSEcCtD
Didanosine—Vomiting—Cisplatin—testicular cancer	0.0011	0.00113	CcSEcCtD
Didanosine—Rash—Cisplatin—testicular cancer	0.00109	0.00112	CcSEcCtD
Didanosine—Dermatitis—Cisplatin—testicular cancer	0.00109	0.00112	CcSEcCtD
Didanosine—Diarrhoea—Etoposide—testicular cancer	0.00108	0.00111	CcSEcCtD
Didanosine—Anaemia—Methotrexate—testicular cancer	0.00107	0.0011	CcSEcCtD
Didanosine—Flatulence—Epirubicin—testicular cancer	0.00107	0.0011	CcSEcCtD
Didanosine—Malaise—Methotrexate—testicular cancer	0.00105	0.00107	CcSEcCtD
Didanosine—Leukopenia—Methotrexate—testicular cancer	0.00104	0.00107	CcSEcCtD
Didanosine—Chills—Doxorubicin—testicular cancer	0.00104	0.00106	CcSEcCtD
Didanosine—Nausea—Cisplatin—testicular cancer	0.00103	0.00105	CcSEcCtD
Didanosine—Alopecia—Doxorubicin—testicular cancer	0.00102	0.00105	CcSEcCtD
Didanosine—Vomiting—Etoposide—testicular cancer	0.00101	0.00103	CcSEcCtD
Didanosine—Anaemia—Epirubicin—testicular cancer	0.001	0.00103	CcSEcCtD
Didanosine—Rash—Etoposide—testicular cancer	0.000998	0.00102	CcSEcCtD
Didanosine—Dermatitis—Etoposide—testicular cancer	0.000997	0.00102	CcSEcCtD
Didanosine—Headache—Etoposide—testicular cancer	0.000992	0.00102	CcSEcCtD
Didanosine—Flatulence—Doxorubicin—testicular cancer	0.000991	0.00102	CcSEcCtD
Didanosine—Arthralgia—Methotrexate—testicular cancer	0.000989	0.00101	CcSEcCtD
Didanosine—Myalgia—Methotrexate—testicular cancer	0.000989	0.00101	CcSEcCtD
Didanosine—Malaise—Epirubicin—testicular cancer	0.00098	0.001	CcSEcCtD
Didanosine—Discomfort—Methotrexate—testicular cancer	0.000977	0.001	CcSEcCtD
Didanosine—Leukopenia—Epirubicin—testicular cancer	0.000973	0.000998	CcSEcCtD
Didanosine—Anaphylactic shock—Methotrexate—testicular cancer	0.000948	0.000972	CcSEcCtD
Didanosine—Infection—Methotrexate—testicular cancer	0.000942	0.000966	CcSEcCtD
Didanosine—Nausea—Etoposide—testicular cancer	0.00094	0.000964	CcSEcCtD
Didanosine—Anaemia—Doxorubicin—testicular cancer	0.00093	0.000953	CcSEcCtD
Didanosine—Thrombocytopenia—Methotrexate—testicular cancer	0.000928	0.000952	CcSEcCtD
Didanosine—Arthralgia—Epirubicin—testicular cancer	0.000925	0.000949	CcSEcCtD
Didanosine—Myalgia—Epirubicin—testicular cancer	0.000925	0.000949	CcSEcCtD
Didanosine—Discomfort—Epirubicin—testicular cancer	0.000914	0.000937	CcSEcCtD
Didanosine—Malaise—Doxorubicin—testicular cancer	0.000907	0.00093	CcSEcCtD
Didanosine—Dry mouth—Epirubicin—testicular cancer	0.000905	0.000928	CcSEcCtD
Didanosine—Anorexia—Methotrexate—testicular cancer	0.000904	0.000926	CcSEcCtD
Didanosine—Leukopenia—Doxorubicin—testicular cancer	0.0009	0.000923	CcSEcCtD
Didanosine—Anaphylactic shock—Epirubicin—testicular cancer	0.000887	0.00091	CcSEcCtD
Didanosine—Infection—Epirubicin—testicular cancer	0.000881	0.000904	CcSEcCtD
Didanosine—Thrombocytopenia—Epirubicin—testicular cancer	0.000869	0.000891	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000864	0.000885	CcSEcCtD
Didanosine—Myalgia—Doxorubicin—testicular cancer	0.000856	0.000878	CcSEcCtD
Didanosine—Arthralgia—Doxorubicin—testicular cancer	0.000856	0.000878	CcSEcCtD
Didanosine—Paraesthesia—Methotrexate—testicular cancer	0.000851	0.000873	CcSEcCtD
Didanosine—Discomfort—Doxorubicin—testicular cancer	0.000846	0.000867	CcSEcCtD
Didanosine—Anorexia—Epirubicin—testicular cancer	0.000846	0.000867	CcSEcCtD
Didanosine—Dry mouth—Doxorubicin—testicular cancer	0.000837	0.000859	CcSEcCtD
Didanosine—Dyspepsia—Methotrexate—testicular cancer	0.000834	0.000856	CcSEcCtD
Didanosine—Decreased appetite—Methotrexate—testicular cancer	0.000824	0.000845	CcSEcCtD
Didanosine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000821	0.000842	CcSEcCtD
Didanosine—Infection—Doxorubicin—testicular cancer	0.000816	0.000836	CcSEcCtD
Didanosine—Pain—Methotrexate—testicular cancer	0.000811	0.000831	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000808	0.000829	CcSEcCtD
Didanosine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000804	0.000824	CcSEcCtD
Didanosine—Paraesthesia—Epirubicin—testicular cancer	0.000797	0.000817	CcSEcCtD
Didanosine—Anorexia—Doxorubicin—testicular cancer	0.000782	0.000802	CcSEcCtD
Didanosine—Dyspepsia—Epirubicin—testicular cancer	0.000781	0.000801	CcSEcCtD
Didanosine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000775	0.000795	CcSEcCtD
Didanosine—Decreased appetite—Epirubicin—testicular cancer	0.000771	0.000791	CcSEcCtD
Didanosine—Pain—Epirubicin—testicular cancer	0.000759	0.000778	CcSEcCtD
Didanosine—Abdominal pain—Methotrexate—testicular cancer	0.000749	0.000768	CcSEcCtD
Didanosine—Body temperature increased—Methotrexate—testicular cancer	0.000749	0.000768	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000748	0.000767	CcSEcCtD
Didanosine—Paraesthesia—Doxorubicin—testicular cancer	0.000737	0.000756	CcSEcCtD
Didanosine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000725	0.000744	CcSEcCtD
Didanosine—Dyspepsia—Doxorubicin—testicular cancer	0.000723	0.000741	CcSEcCtD
Didanosine—Decreased appetite—Doxorubicin—testicular cancer	0.000714	0.000732	CcSEcCtD
Didanosine—Pain—Doxorubicin—testicular cancer	0.000702	0.00072	CcSEcCtD
Didanosine—Abdominal pain—Epirubicin—testicular cancer	0.000701	0.000719	CcSEcCtD
Didanosine—Body temperature increased—Epirubicin—testicular cancer	0.000701	0.000719	CcSEcCtD
Didanosine—Hypersensitivity—Methotrexate—testicular cancer	0.000698	0.000716	CcSEcCtD
Didanosine—Asthenia—Methotrexate—testicular cancer	0.00068	0.000697	CcSEcCtD
Didanosine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000671	0.000688	CcSEcCtD
Didanosine—Pruritus—Methotrexate—testicular cancer	0.000671	0.000688	CcSEcCtD
Didanosine—Hypersensitivity—Epirubicin—testicular cancer	0.000654	0.00067	CcSEcCtD
Didanosine—Body temperature increased—Doxorubicin—testicular cancer	0.000649	0.000665	CcSEcCtD
Didanosine—Abdominal pain—Doxorubicin—testicular cancer	0.000649	0.000665	CcSEcCtD
Didanosine—Diarrhoea—Methotrexate—testicular cancer	0.000649	0.000665	CcSEcCtD
Didanosine—Asthenia—Epirubicin—testicular cancer	0.000637	0.000653	CcSEcCtD
Didanosine—Pruritus—Epirubicin—testicular cancer	0.000628	0.000643	CcSEcCtD
Didanosine—Diarrhoea—Epirubicin—testicular cancer	0.000607	0.000622	CcSEcCtD
Didanosine—Hypersensitivity—Doxorubicin—testicular cancer	0.000605	0.00062	CcSEcCtD
Didanosine—Vomiting—Methotrexate—testicular cancer	0.000603	0.000618	CcSEcCtD
Didanosine—Rash—Methotrexate—testicular cancer	0.000598	0.000613	CcSEcCtD
Didanosine—Dermatitis—Methotrexate—testicular cancer	0.000597	0.000612	CcSEcCtD
Didanosine—Headache—Methotrexate—testicular cancer	0.000594	0.000609	CcSEcCtD
Didanosine—Asthenia—Doxorubicin—testicular cancer	0.000589	0.000604	CcSEcCtD
Didanosine—Pruritus—Doxorubicin—testicular cancer	0.000581	0.000595	CcSEcCtD
Didanosine—Vomiting—Epirubicin—testicular cancer	0.000564	0.000578	CcSEcCtD
Didanosine—Nausea—Methotrexate—testicular cancer	0.000563	0.000577	CcSEcCtD
Didanosine—Diarrhoea—Doxorubicin—testicular cancer	0.000562	0.000576	CcSEcCtD
Didanosine—Rash—Epirubicin—testicular cancer	0.000559	0.000573	CcSEcCtD
Didanosine—Dermatitis—Epirubicin—testicular cancer	0.000559	0.000573	CcSEcCtD
Didanosine—Headache—Epirubicin—testicular cancer	0.000556	0.00057	CcSEcCtD
Didanosine—Nausea—Epirubicin—testicular cancer	0.000527	0.00054	CcSEcCtD
Didanosine—Vomiting—Doxorubicin—testicular cancer	0.000522	0.000535	CcSEcCtD
Didanosine—Rash—Doxorubicin—testicular cancer	0.000518	0.000531	CcSEcCtD
Didanosine—Dermatitis—Doxorubicin—testicular cancer	0.000517	0.00053	CcSEcCtD
Didanosine—Headache—Doxorubicin—testicular cancer	0.000514	0.000527	CcSEcCtD
Didanosine—Nausea—Doxorubicin—testicular cancer	0.000488	0.0005	CcSEcCtD
